COVID-19 Vaccine Update: NTAGI Approves Corbevax, Covaxin for 5-12 Years Age Group, Say Sources
According to the sources, no decision on introducing these vaccines in the Covid-19 vaccination programme was taken. The National Technical Advisory Group on Immunisation (NTAGI) working group Covid-19 had reviewed the data of Covid-19 vaccines for the children in the age group 5-12 years in the last month.
New Delhi, July 8: The National Technical Advisory Group on Immunisation's (NTAGI) Standing Technical Sub-Committee (STSC) has given a nod for the use of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between 5-12 years, sources informed on Friday.
According to the sources, no decision on introducing these vaccines in the Covid-19 vaccination programme was taken. The National Technical Advisory Group on Immunisation (NTAGI) working group Covid-19 had reviewed the data of Covid-19 vaccines for the children in the age group 5-12 years in the last month. Beijing Announces COVID-19 Vaccine Mandate for Its Residents.
Recently, the Drugs Controller General of India (DCGI) granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the age group of 6-12 years. The development came after Prime Minister Narendra Modi stressed the availability of Covid-19 vaccination for all eligible children at the earliest with "special campaigns" in schools as the government's priority.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)